Mark J. Rosenblum
2023 - Flex Pharma
In 2023, Mark J. Rosenblum earned a total compensation of $355.8K as Executive Vice President, Finance and Chief Financial Officer at Flex Pharma, a 28% decrease compared to previous year.
Compensation breakdown
| Salary | $330,000 |
|---|---|
| Stock Awards | $12,560 |
| Other | $13,200 |
| Total | $355,760 |
Rosenblum received $330K in salary, accounting for 93% of the total pay in 2023.
Rosenblum also received $12.6K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Mark J. Rosenblum's compensation ranked 2,258th out of 2,785 executives tracked by ExecPay. In other words, Rosenblum earned more than 18.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,258 out of 2,785 | 19th |
Division Manufacturing | 1,263 out of 1,525 | 17th |
Major group Chemicals And Allied Products | 752 out of 864 | 13th |
Industry group Drugs | 733 out of 827 | 11th |
Industry Pharmaceutical Preparations | 524 out of 592 | 12th |
Source: SEC filing on November 1, 2024.
Rosenblum's colleagues
We found one more compensation record of an executive who worked with Mark J. Rosenblum at Flex Pharma in 2023.
2023
David and
Flex Pharma